Detalles de la búsqueda
1.
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Oncologist
; 29(1): e141-e151, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463014
2.
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework.
Int J Gynecol Cancer
; 33(11): 1708-1714, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875322
3.
First and further-line multidisciplinary treatment of retroperitoneal sarcomas.
Curr Opin Oncol
; 34(4): 328-334, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837704
4.
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Curr Treat Options Oncol
; 23(3): 439-449, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275323
5.
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Int J Mol Sci
; 23(18)2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142281
6.
Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors.
Eur Radiol
; 31(11): 8554-8564, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33881567
7.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Cancer
; 126(21): 4726-4734, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749681
8.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer
; 126(11): 2637-2647, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32129883
9.
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.
J Transl Med
; 18(1): 494, 2020 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33380328
10.
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Lancet Oncol
; 19(10): 1360-1371, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30217671
11.
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
Mol Cancer
; 16(1): 86, 2017 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454547
12.
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
Biol Blood Marrow Transplant
; 23(3): 459-466, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039079
13.
Preventing Venous Thromboembolism in Patients with Cancer.
N Engl J Med
; 380(22): 2180-2181, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31141644
14.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
BMC Cancer
; 17(1): 266, 2017 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407756
15.
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.
Lancet Oncol
; 16(1): 98-107, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25498219
16.
Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.
Cancer
; 126(20): 4615-4616, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32767667
17.
Eribulin-based treatment in patients affected by sarcomas: a case series.
Future Oncol
; 16(1s): 1-3, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31840540
18.
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
Expert Opin Ther Targets
; 28(1-2): 17-28, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38234142
19.
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
EBioMedicine
; 101: 105003, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340557
20.
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group.
Cancer Treat Rev
; 126: 102722, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38604052